To improve life during and beyond sedation
Sedana Medical is a pioneer medtech and pharmaceutical company dedicated to making inhaled sedation a standard therapy in intensive care.More about us
Bringing inhaled sedation to intensive care
We are proud to introduce inhaled sedation to intensive care, a paradigm shift in the care of critically ill patients.
Through the results obtained in the pivotal study with Sedaconda (isoflurane) and Sedaconda ACD*, we have laid the foundation for inhaled sedation in intensive care.
By this, we have also taken a major step closer to our vision – to make inhaled sedation a standard therapy in intensive care.
*formerly known as AnaConDa
Science & Clinical Research
We pave the way for a paradigm shift in sedation in intensive care through knowledge sharing and clinical research.
Sedasource is an online resource for healthcare professionals, providing scientific and clinical material on the sedation of critically ill patients.
Our research aims at a greater understanding of and increased knowledge about inhaled sedation, leading to medical advances for the benefit of patients in intensive care.
We also believe in working in partnerships – through various initiatives and research projects – that can lead to continued development and meaningful improvement for both patients and the healthcare system.
Sedana Medical AB’s Year-end report 2022
Fast track designation in the US and our strongest quarter in 2022
Sedana Medical receives market approval in Italy
Sedana Medical AB (publ) has received market approval for Sedaconda[®] (isoflurane) for inhaled seda…
Explore our broad portfolio of products for the administration of inhaled anaesthetics.
Sedaconda ACD-S is a medical device which enables the administration of volatile anaesthetics (isofl…
FlurAbsorb is an active carbon filter, developed by Sedana Medical to capture waste anaesthetic gase…
AMG-06 Gas Monitor
AMG-06 Gas Monitor is intended for continuous non-invasive sidestream monitoring of CO2 & anaest…